Cancer stem cells - the current status of an old concept: Literature review and clinical approaches

Biological Research

Volumn 47, Issue 1, 2014, Pages

  Fulawka, Lukasz ^a,b   Donizy, Piotr ^a   Halon, Agnieszka ^a  

^a WROCLAW MEDICAL UNIVERSITY   (Poland)

^b Dolnoslaskie Centrum Onkologii Wroclaw   (Poland)

Author keywords

Cancer stem cells; Carcinogenesis; Clonal evolution; Stem cells; Tumour heterogeneity; Tumour initiating cells; Tumour propagating cells

Indexed keywords

FLUORESCENT DYE; TUMOR MARKER;

ANIMAL; CANCER STEM CELL; CARCINOGENESIS; CELL DIFFERENTIATION; CELL SELF-RENEWAL; CLONAL EVOLUTION; DRUG RESISTANCE; EXTRACELLULAR MATRIX; FLOW CYTOMETRY; MICROVASCULATURE; PATHOLOGY; PATHOPHYSIOLOGY; PHYSIOLOGY; PROGNOSIS; SCID MOUSE; STROMA CELL; TUMOR MICROENVIRONMENT;

ANIMALS; BIOMARKERS, TUMOR; CARCINOGENESIS; CELL DIFFERENTIATION; CELL SELF RENEWAL; CLONAL EVOLUTION; DRUG RESISTANCE, NEOPLASM; EXTRACELLULAR MATRIX; FLOW CYTOMETRY; FLUORESCENT DYES; MICE, SCID; MICROVESSELS; NEOPLASTIC STEM CELLS; PROGNOSIS; STROMAL CELLS; TUMOR MICROENVIRONMENT;

EID: 84930761557     PISSN: 07169760     EISSN: 07176287     Source Type: Journal    
DOI: 10.1186/0717-6287-47-66     Document Type: Review

References (59)

1. Lapidot T, Sirard C, Vormoor J, Murdoch B, Hoang T, Cacerescortes J, Minden M, Paterson B, Caligiuri MA, Dick JE: A cell initiating human acute myeloid-leukemia after transplantation into SCID mice. Nature 1994, 367:645-648
2. Sell S: Stem cells and cancer: an introduction. In Stem Cells and Cancer. Edited by Majumder S. New York: Springer; 2009:1-31
3. Reya T, Morrison SJ, Clarke MF, Weissman IL: Stem cells, cancer, and cancer stem cells. Nature 2001, 414:105-111
4. Lanza RGJ, Hogan B, Melton D, Pedersen R, Thomas ED, Thomson J, Wilmut I: Essentials of Stem Cell Biology. 2009:xxii-xxix
5. Jansen J, Thompson JM, Dugan MJ, Nolan P, Wiemann MC, Birhiray R, Henslee-Downey PJ, Akard LP: Peripheral blood progenitor cell transplantation. Ther Apher 2002, 6:5-14
6. Makino S: Further evidence favoring the concept of the stem cell in ascites tumors of rats. Ann N Y Acad Sci 1956, 63:818-830
7. Oliveira LR: Stem cells and cancer stem cells. In Cancer Stem Cells-The Cutting Edge. Edited by Shostak S. Rijeka: InTech; 2011:3-28
8. Fulawka L, Donizy P, Halon A: Yamanaka's factors and core transcription factors-the molecular link between embryogenesis and carcinogenesis. Postepy Hig Med Dosw 2014, 68:715-721
9. Pierce GB, Speers WC: Tumors as caricatures of the process of tissue renewal-prospects for therapy by directing differentiation. Cancer Res 1988, 48:1996-2004
10. Azmi AS: Systems and network understanding of cancer stem cells. In Cancer Stem Cells-The Cutting Edge. Edited by Shostak S. Rijeka: InTech; 2011:135-146
11. Teicher BA: Tumor stem cells and malignant cells, one and the same. In Stem Cells and Cancer. Edited by Bagley RG. New York: Humana Pres; 2009:15-26
12. Hamburger AW, Salmon SE: Primary bioassay of human tumor stem cells. Science 1977, 197:461-463
13. Clarke MF, Dick JE, Dirks PB, Eaves CJ, Jamieson CHM, Jones DL, Visvader J, Weissman IL, Wahl GM: Cancer stem cells-perspectives on current status and future directions: AACR Workshop on cancer stem cells. Cancer Res 2006, 66:9339-9344
14. Grotenhuis BA, Wijnhoven BPL, Van Lanschot JJB: Cancer stem cells and their potential implications for the treatment of solid tumors. J Surg Oncol 2012, 106:209-215
15. McKenzie JL, Gan OI, Doedens M, Dick JE: Human short-term repopulating stem cells are efficiently detected following intrafemoral transplantation into NOD/SCID recipients depleted of CD122(+) cells. Blood 2005, 106:1259-1261
16. Kelly PN, Dakic A, Adams JM, Nutt SL, Strasser A: Tumor growth need not be driven by rare cancer stem cells. Science 2007, 317:337-337
17. Wieczorek K, Niewiarowska J: Cancer stem cells. Postepy Hig Med Dosw 2012, 66:629-636
18. Foreman KE, Rizzo OCP, Miele L: The cancer stem cell hypothesis. In Stem Cells and Cancer. Edited by Bagley RG. ; 2009
19. Floor S, van Staveren WCG, Larsimont D, Dumont JE, Maenhaut C: Cancer cells in epithelial-to-mesenchymal transition and tumor-propagating-cancer stem cells: distinct, overlapping or same populations. Oncogene 2011, 30:4609-4621
20. Marusyk A, Polyak K: Tumor heterogeneity: causes and consequences. Biochimica Et Biophysica Acta-Reviews on Cancer 2010, 1805:105-117
21. Marusyk A, Almendro V, Polyak K: Intra-tumour heterogeneity: a looking glass for cancer? Nat Rev Cancer 2012, 12:323-334
22. Saunders NA, Simpson F, Thompson EW, Hill MM, Endo-Munoz L, Leggatt G, Minchin RF, Guminski A: Role of intratumoural heterogeneity in cancer drug resistance: molecular and clinical perspectives. Embo Mol Med 2012, 4:675-684
23. Russnes HG, Navin N, Hicks J, Borresen-Dale A-L: Insight into the heterogeneity of breast cancer through next-generation sequencing. J Clin Invest 2011, 121:3810-3818
24. Shackleton M, Quintana E, Fearon ER, Morrison SJ: Heterogeneity in cancer: cancer stem cells versus clonal evolution. Cell 2009, 138:822-829
25. Shiozawa Y, Nie B, Pienta KJ, Morgan TM, Taichman RS: Cancer stem cells and their role in metastasis. Pharmacol Ther 2013, 138:285-293
26. Nguyen LV, Vanner R, Dirks P, Eaves CJ: Cancer stem cells: an evolving concept. Nat Rev Cancer 2012, 12:133-143
27. Cozzio A, Passegue E, Ayton PM, Karsunky H, Cleary ML, Weissman IL: Similar MLL-associated leukemias arising from self-renewing stem cells and short-lived myeloid progenitors. Genes Dev 2003, 17:3029-3035
28. Chang JT, Mani SA: Sheep, wolf, or werewolf: cancer stem cells and the epithelial-to-mesenchymal transition. Cancer Lett 2013, 341:16-23
29. Singh A, Settleman J: EMT, cancer stem cells and drug resistance: an emerging axis of evil in the war on cancer. Oncogene 2010, 29:4741-4751
30. Beck B, Blanpain C: Unravelling cancer stem cell potential. Nat Rev Cancer 2013, 13:727-738
31. Jones DL: Stem cell niches. In Essentials of Stem Cell Biology. Edited by Lanza R. ; 2009:61-72
32. Honoki K, Fujii H, Tsujiuchi T: Cancer stem cell niche: the role of mesenchymal stem cells in tumor microenvironment. In Cancer Stem Cells-The Cutting Edge. Edited by Shostak S. Rijeka: InTech; 2011:189-206
33. Clarke MF, Fuller M: Stem cells and cancer: two faces of eve. Cell 2006, 124:1111-1115
34. Greve B, Kelsch R, Spaniol K, Eich HT, Gotte M: Flow cytometry in cancer stem cell analysis and separation. Cytometry Part A 2012, 81A:284-293
35. Scharenberg CW, Harkey MA, Torok-Storb B: The ABCG2 transporter is an efficient Hoechst 33342 efflux pump and is preferentially expressed by immature human hematopoietic progenitors. Blood 2002, 99:507-512
36. Hung JY: Cancer stem cells: lung cancer. In Stem Cells and Cancer. Edited by Bagley RG. New York: Humana Pres; 2009:177-184
37. Al-Hajj M, Wicha MS, Benito-Hernandez A, Morrison SJ, Clarke MF: Prospective identification of tumorigenic breast cancer cells. Proc Natl Acad Sci U S A 2003, 100:3983-3988
38. Collins AT, Berry PA, Hyde C, Stower MJ, Maitland NJ: Prospective identification of tumorigenic prostate cancer stem cells. Cancer Res 2005, 65:10946-10951
39. Li C, Heidt DG, Dalerba P, Burant CF, Zhang L, Adsay V, Wicha M, Clarke MF, Simeone DM: Identification of pancreatic cancer stem cells. Cancer Res 2007, 67:1030-1037
40. Prince ME, Sivanandan R, Kaczorowski A, Wolf GT, Kaplan MJ, Dalerba P, Weissman IL, Clarke MF, Ailles LE: Identification of a subpopulation of cells with cancer stem cell properties in head and neck squamous cell carcinoma. Proc Natl Acad Sci U S A 2007, 104:973-978
41. Singh SK, Hawkins C, Clarke ID, Squire JA, Bayani J, Hide T, Henkelman RM, Cusimano MD, Dirks PB: Identification of human brain tumour initiating cells. Nature 2004, 432:396-401
42. Ricci-Vitiani L, Lombardi DG, Pilozzi E, Biffoni M, Todaro M, Peschle C, De Maria R: Identification and expansion of human colon-cancer-initiating cells. Nature 2007, 445:111-115
43. O'Brien CA, Pollett A, Gallinger S, Dick JE: A human colon cancer cell capable of initiating tumour growth in immunodeficient mice. Nature 2007, 445:106-110
44. Eramo A, Lotti F, Sette G, Pilozzi E, Biffoni M, Di Virgilio A, Conticello C, Ruco L, Peschle C, De Maria R: Identification and expansion of the tumorigenic lung cancer stem cell population. Cell Death Differ 2008, 15:504-514
45. Yang ZF, Ho DW, Ng MN, Lau CK, Yu WC, Ngai P, Chu PWK, Lam CT, Poon RTP, Fan ST: Significance of CD90(+) cancer stem cells in human liver cancer. Cancer Cell 2008, 13:153-166
46. Takahashi K, Yamanaka S: Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors. Cell 2006, 126:663-676
47. Yu J, Vodyanik MA, Smuga-Otto K, Antosiewicz-Bourget J, Frane JL, Tian S, Nie J, Jonsdottir GA, Ruotti V, Stewart R, Slukvin II, Thomson JA: Induced pluripotent stem cell lines derived from human somatic cells. Science 2007, 318:1917-1920
48. Gu G, Yuan J, Wils M, Kasper S: Prostate cancer cells with stem cell characteristics reconstitute the original human tumor in vivo. Cancer Res 2007, 67:4807-4815
49. Wang PX, Branch DR, Bali M, Schultz GA, Goss PE, Jin TR: The POU homeodomain protein OCT3 as a potential transcriptional activator for fibroblast growth factor-4 (FGF-4) in human breast cancer cells. Biochem J 2003, 375:199-205
50. Ma N, Thanan R, Kobayashi H, Hammam O, Wishahi M, El Leithy T, Hiraku Y, Amro E-K, Oikawa S, Ohnishi S, Murata M, Kawanishi S: Nitrative DNA damage and Oct3/4 expression in urinary bladder cancer with Schistosoma haematobium infection. Biochem Biophys Res Commun 2011, 414:344-349
51. Ginestier C, Hur MH, Charafe-Jauffret E, Monville F, Dutcher J, Brown M, Jacquemier J, Viens P, Kleer CG, Liu SL, Schott A, Hayes D, Birnbaum D, Wicha MS, Dontu G: ALDH1 is a marker of normal and malignant human mammary stem cells and a predictor of poor clinical outcome. Cell Stem Cell 2007, 1:555-567
52. Pearce DJ, Taussig D, Simpson C, Allen K, Rohatiner AZ, Lister TA, Bonnet D: Characterization of cells with a high aldehyde dehydrogenase activity from cord blood and acute myeloid leukemia samples. Stem Cells 2005, 23:752-760
53. Li T, Su Y, Mei Y, Leng Q, Leng B, Liu Z, Stass SA, Jiang F: ALDH1A1 is a marker for malignant prostate stem cells and predictor of prostate cancer patients' outcome. Lab Invest 2010, 90:234-244
54. Ma S, Chan KW, Lee TK-W, Tang KH, Wo JY-H, Zheng B-J, Guan X-Y: Aldehyde dehydrogenase discriminates the CD133 liver cancer stem cell populations. Cancer Res 2008, 6:1146-1153
55. Battula VL, Shi YX, Evans KW, Wang RY, Spaeth EL, Jacamo RO, Guerra R, Sahin AA, Marini FC, Hortobagyi G, Mani SA, Andreeff M: Ganglioside GD2 identifies breast cancer stem cells and promotes tumorigenesis. J Clin Invest 2012, 122:2066-2078
56. Beier D, Hau P, Proescholdt M, Lohmeier A, Wischhusen J, Oefner PJ, Aigner L, Brawanski A, Bogdahn U, Beier CP: CD133(+) and CD133(-) glioblastomaderived cancer stem cells show differential growth characteristics and molecular profiles. Cancer Res 2007, 67:4010-4015
57. Beier D, Wischhusen J, Dietmaier W, Hau P, Proescholdt M, Brawanski A, Bogdahn U, Beier CP: CD133 expression and cancer stem cells predict prognosis in high-grade oligodendroglial tumors. Brain Pathol 2008, 18:370-377
58. Ahmed AU, Thaci B, Wainwright DA, Dey M, Lesniak MS: Therapeutic strategies targeting cancer stem cells. In Cancer Stem Cells-The Cutting Edge. Edited by Shostak S. Rijeka: InTech; 2011:375-388
59. Erenpreisa J, Cragg MS: Three steps to the immortality of cancer cells: senescence, polyploidy and self-renewal. Cancer Cell Int 2013, 13:92